Comparative Analysis of Single‐ and Dual‐Marker Strategies for Rapid Non–ST‐Segment–Elevation Myocardial Infarction Rule‐Out Using Cardiac Myosin‐Binding Protein C, Copeptin, and High‐Sensitivity Cardiac Troponin T in the Emergency Department

Background This study compared the diagnostic and prognostic performance of various non–ST‐segment myocardial infarction (NSTEMI) rule‐out protocols, incorporating cardiac myosin‐binding protein C (cMyBP‐C), high‐sensitivity cardiac troponin T (hs‐cTnT), and Copeptin, both individually and as part o...

Full description

Saved in:
Bibliographic Details
Main Authors: Mustafa Yildirim, Christian Salbach, Matthias Mueller‐Hennessen, Norbert Frey, Evangelos Giannitsis
Format: Article
Language:English
Published: Wiley 2025-05-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.124.039379
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850266566424264704
author Mustafa Yildirim
Christian Salbach
Matthias Mueller‐Hennessen
Norbert Frey
Evangelos Giannitsis
author_facet Mustafa Yildirim
Christian Salbach
Matthias Mueller‐Hennessen
Norbert Frey
Evangelos Giannitsis
author_sort Mustafa Yildirim
collection DOAJ
description Background This study compared the diagnostic and prognostic performance of various non–ST‐segment myocardial infarction (NSTEMI) rule‐out protocols, incorporating cardiac myosin‐binding protein C (cMyBP‐C), high‐sensitivity cardiac troponin T (hs‐cTnT), and Copeptin, both individually and as part of dual‐marker strategies (DMSs) against the European Society of Cardiology 0/1‐hour and 0/3‐hour algorithms. Methods We enrolled 1765 patients presenting to the emergency department with suspected NSTEMI. We evaluated biomarker algorithms including cMyBP‐C (<10 ng/L, <2.3 ng/L), hs‐cTnT (limit of blank [<3 ng/L], limit of detection [<5 ng/L], 99th percentile [≤14 ng/L]), and DMS combinations of copeptin (<10 pmol/L) with hs‐cTnT, cMyBP‐C with hs‐cTnT, and copeptin with cMyBP‐C. The European Society of Cardiology 0/1‐hour and 0/3‐hour algorithms were also tested. We calculated negative predictive values and sensitivities for NSTEMI rule‐out and assessed effectiveness and prognostic performance based on cardiovascular events within 30 days and 1 year. Results The areas under the curve were 0.922 for hs‐cTnT, 0.917 for cMyBP‐C, and 0.624 for copeptin in diagnosing NSTEMI. DMS protocols showed negative predictive values of 99.1% to 100%, comparable with the European Society of Cardiology algorithms (99.3%–100%). Sensitivities for DMS ranged from 96.2% to 100%. All protocols had low rates of the combined end point of cardiovascular events within 30 days (0.0%–0.6%). Conclusions The European Society of Cardiology 0/1‐hour algorithm and DMS combining hs‐cTnT with either cMyBP‐C or copeptin provide highly reliable and safe protocols for NSTEMI rule‐out. These DMS approaches offer promising alternatives to current standards, potentially improving clinical decision making and efficiency in emergency departments. Registration URL: https://clinicaltrials.gov; Unique identifier: NCT06128317
format Article
id doaj-art-650da4f96821468daabb8ada9f65cf96
institution OA Journals
issn 2047-9980
language English
publishDate 2025-05-01
publisher Wiley
record_format Article
series Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
spelling doaj-art-650da4f96821468daabb8ada9f65cf962025-08-20T01:54:08ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802025-05-01141010.1161/JAHA.124.039379Comparative Analysis of Single‐ and Dual‐Marker Strategies for Rapid Non–ST‐Segment–Elevation Myocardial Infarction Rule‐Out Using Cardiac Myosin‐Binding Protein C, Copeptin, and High‐Sensitivity Cardiac Troponin T in the Emergency DepartmentMustafa Yildirim0Christian Salbach1Matthias Mueller‐Hennessen2Norbert Frey3Evangelos Giannitsis4Department of Internal Medicine III, Cardiology University Hospital of Heidelberg Heidelberg GermanyDepartment of Internal Medicine III, Cardiology University Hospital of Heidelberg Heidelberg GermanyDepartment of Internal Medicine III, Cardiology University Hospital of Heidelberg Heidelberg GermanyDepartment of Internal Medicine III, Cardiology University Hospital of Heidelberg Heidelberg GermanyDepartment of Internal Medicine III, Cardiology University Hospital of Heidelberg Heidelberg GermanyBackground This study compared the diagnostic and prognostic performance of various non–ST‐segment myocardial infarction (NSTEMI) rule‐out protocols, incorporating cardiac myosin‐binding protein C (cMyBP‐C), high‐sensitivity cardiac troponin T (hs‐cTnT), and Copeptin, both individually and as part of dual‐marker strategies (DMSs) against the European Society of Cardiology 0/1‐hour and 0/3‐hour algorithms. Methods We enrolled 1765 patients presenting to the emergency department with suspected NSTEMI. We evaluated biomarker algorithms including cMyBP‐C (<10 ng/L, <2.3 ng/L), hs‐cTnT (limit of blank [<3 ng/L], limit of detection [<5 ng/L], 99th percentile [≤14 ng/L]), and DMS combinations of copeptin (<10 pmol/L) with hs‐cTnT, cMyBP‐C with hs‐cTnT, and copeptin with cMyBP‐C. The European Society of Cardiology 0/1‐hour and 0/3‐hour algorithms were also tested. We calculated negative predictive values and sensitivities for NSTEMI rule‐out and assessed effectiveness and prognostic performance based on cardiovascular events within 30 days and 1 year. Results The areas under the curve were 0.922 for hs‐cTnT, 0.917 for cMyBP‐C, and 0.624 for copeptin in diagnosing NSTEMI. DMS protocols showed negative predictive values of 99.1% to 100%, comparable with the European Society of Cardiology algorithms (99.3%–100%). Sensitivities for DMS ranged from 96.2% to 100%. All protocols had low rates of the combined end point of cardiovascular events within 30 days (0.0%–0.6%). Conclusions The European Society of Cardiology 0/1‐hour algorithm and DMS combining hs‐cTnT with either cMyBP‐C or copeptin provide highly reliable and safe protocols for NSTEMI rule‐out. These DMS approaches offer promising alternatives to current standards, potentially improving clinical decision making and efficiency in emergency departments. Registration URL: https://clinicaltrials.gov; Unique identifier: NCT06128317https://www.ahajournals.org/doi/10.1161/JAHA.124.039379acute coronary syndromecardiac myosin‐binding protein Ccardiac troponinemergency departmenthigh‐sensitivity
spellingShingle Mustafa Yildirim
Christian Salbach
Matthias Mueller‐Hennessen
Norbert Frey
Evangelos Giannitsis
Comparative Analysis of Single‐ and Dual‐Marker Strategies for Rapid Non–ST‐Segment–Elevation Myocardial Infarction Rule‐Out Using Cardiac Myosin‐Binding Protein C, Copeptin, and High‐Sensitivity Cardiac Troponin T in the Emergency Department
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
acute coronary syndrome
cardiac myosin‐binding protein C
cardiac troponin
emergency department
high‐sensitivity
title Comparative Analysis of Single‐ and Dual‐Marker Strategies for Rapid Non–ST‐Segment–Elevation Myocardial Infarction Rule‐Out Using Cardiac Myosin‐Binding Protein C, Copeptin, and High‐Sensitivity Cardiac Troponin T in the Emergency Department
title_full Comparative Analysis of Single‐ and Dual‐Marker Strategies for Rapid Non–ST‐Segment–Elevation Myocardial Infarction Rule‐Out Using Cardiac Myosin‐Binding Protein C, Copeptin, and High‐Sensitivity Cardiac Troponin T in the Emergency Department
title_fullStr Comparative Analysis of Single‐ and Dual‐Marker Strategies for Rapid Non–ST‐Segment–Elevation Myocardial Infarction Rule‐Out Using Cardiac Myosin‐Binding Protein C, Copeptin, and High‐Sensitivity Cardiac Troponin T in the Emergency Department
title_full_unstemmed Comparative Analysis of Single‐ and Dual‐Marker Strategies for Rapid Non–ST‐Segment–Elevation Myocardial Infarction Rule‐Out Using Cardiac Myosin‐Binding Protein C, Copeptin, and High‐Sensitivity Cardiac Troponin T in the Emergency Department
title_short Comparative Analysis of Single‐ and Dual‐Marker Strategies for Rapid Non–ST‐Segment–Elevation Myocardial Infarction Rule‐Out Using Cardiac Myosin‐Binding Protein C, Copeptin, and High‐Sensitivity Cardiac Troponin T in the Emergency Department
title_sort comparative analysis of single and dual marker strategies for rapid non st segment elevation myocardial infarction rule out using cardiac myosin binding protein c copeptin and high sensitivity cardiac troponin t in the emergency department
topic acute coronary syndrome
cardiac myosin‐binding protein C
cardiac troponin
emergency department
high‐sensitivity
url https://www.ahajournals.org/doi/10.1161/JAHA.124.039379
work_keys_str_mv AT mustafayildirim comparativeanalysisofsingleanddualmarkerstrategiesforrapidnonstsegmentelevationmyocardialinfarctionruleoutusingcardiacmyosinbindingproteinccopeptinandhighsensitivitycardiactroponintintheemergencydepartment
AT christiansalbach comparativeanalysisofsingleanddualmarkerstrategiesforrapidnonstsegmentelevationmyocardialinfarctionruleoutusingcardiacmyosinbindingproteinccopeptinandhighsensitivitycardiactroponintintheemergencydepartment
AT matthiasmuellerhennessen comparativeanalysisofsingleanddualmarkerstrategiesforrapidnonstsegmentelevationmyocardialinfarctionruleoutusingcardiacmyosinbindingproteinccopeptinandhighsensitivitycardiactroponintintheemergencydepartment
AT norbertfrey comparativeanalysisofsingleanddualmarkerstrategiesforrapidnonstsegmentelevationmyocardialinfarctionruleoutusingcardiacmyosinbindingproteinccopeptinandhighsensitivitycardiactroponintintheemergencydepartment
AT evangelosgiannitsis comparativeanalysisofsingleanddualmarkerstrategiesforrapidnonstsegmentelevationmyocardialinfarctionruleoutusingcardiacmyosinbindingproteinccopeptinandhighsensitivitycardiactroponintintheemergencydepartment